Who is sponsoring NCT03247231?

NCT03247231 is sponsored by Joan B Gornals.

What drugs are being tested in NCT03247231?

Interventions in NCT03247231: Endoscopic band ligation without resection, SINK.

What condition does NCT03247231 study?

NCT03247231 studies Gastrointestinal Subepithelial Tumors.

Is NCT03247231 still recruiting?

NCT03247231 is currently terminated. Last updated 7 September 2022.

Last reviewed 2022-09-07 · How we verify

NCT03247231: BANDING-SET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Banding Without Resection in Small Subepithelial Tumours

Terminated Last updated 7 September 2022

What this trial tests

trial testing Endoscopic band ligation without resection in Gastrointestinal Subepithelial Tumors in 157 participants. Terminated before completion.

Timeline

31 March 2017

Primary endpoint
30 April 2020

30 March 2021

Quick facts

Lead sponsor	Joan B Gornals
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	157
Start date	31 March 2017
Primary completion	30 April 2020
Estimated completion	30 March 2021
Sites	7 locations across Spain

Drugs / interventions tested

Endoscopic band ligation without resection
SINK

Conditions studied

Gastrointestinal Subepithelial Tumors — all drugs for Gastrointestinal Subepithelial Tumors →

Sponsor

Joan B Gornals

Who can join

Adults 18 to 80, any sex, with Gastrointestinal Subepithelial Tumors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To analyse the effectiveness and safety of endoscopic band ligation without resection in small gastrointestinal subepithelial tumours.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

UEG Week 2019 Poster Presentations.
· 2019 · cited 5× · PMID 32213001 · DOI 10.1177/2050640619854671
Management of small subepithelial tumors by endoscopic banding without resection and single-incision needle-knife-assisted biopsy sampling: a prospective multicenter study.
Bas-Cutrina F, Loras C, Pardo A, Ballester-Clau R, et al · · 2023 · cited 3× · PMID 37263361 · DOI 10.1016/j.gie.2023.05.057
UEG Week 2021 Oral Presentations
· 2021

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03247231 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Joan B Gornals
Last refreshed: 7 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03247231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing